Prepared by MERRILL CORPORATION
QuickLinks -- Click here to rapidly navigate through this document

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Schedule 13G

Under the Securities Exchange Act of 1934
(Amendment No. 23)*



Abbott Laboratories
(Name of Issuer)

Common Stock without par value
(Title of Class of Securities)

002824 10 0
(CUSIP Number)

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

(Continued on following page(s))

Page 1 of 12 Pages

CUSIP No. 002824 10 0 13G Page 2 of 12 Pages

1   NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

 
 
Abbott Laboratories Stock Retirement Trust
I.R.S. Identification No. 36-6047554
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 
 
 
 
 
 
 
 
(a)
 
/ /
                (b)   /x/
3   SEC USE ONLY

 
 
 
 
 
 
 
 
 
 
 
4   CITIZENSHIP OR PLACE OF ORGANIZATION

 
 
Illinois
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH   5   SOLE VOTING POWER
            0
       
        6   SHARED VOTING POWER

 
 
 
 
 
 
91,335,667
       
        7   SOLE DISPOSITIVE POWER

 
 
 
 
 
 
0
       
        8   SHARED DISPOSITIVE POWER

 
 
 
 
 
 
91,335,667
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 
 
91,335,667
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 
 
 
 
 
 
 
 
 
 
 
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 
 
5.6%
12   TYPE OF REPORTING PERSON*

 
 
EP

*SEE INSTRUCTIONS

CUSIP No. 002824 10 0 13G Page 3 of 12 Pages


 
 
1   NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

 
 
Thomas C. Freyman
351-50-3912
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 
 
 
 
 
 
 
 
(a)
 
/ /
                (b)   /x/
3   SEC USE ONLY

 
 
 
 
 
 
 
 
 
 
 
4   CITIZENSHIP OR PLACE OF ORGANIZATION

 
 
United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH   5   SOLE VOTING POWER
            14,232 shares— (Does not include shares held in the Abbott
            direct Laboratories Stock Retirement Trust for the benefit of the reporting person.)
       
        6   SHARED VOTING POWER

 
 
 
 
 
 
94,484,681—See Attached Exhibit 1
       
        7   SOLE DISPOSITIVE POWER

 
 
 
 
 
 
14,232 shares (see note in 5 above)
direct
       
        8   SHARED DISPOSITIVE POWER

 
 
 
 
 
 
94,484,681—See Attached Exhibit 1
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 
 
94,698,511—(Total of 5 + 6 + 199,598 shares—right to acquire by exercise of stock options.)
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 
 
 
 
 
 
 
 
 
 
 
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 
 
5.7%
12   TYPE OF REPORTING PERSON*

 
 
IN

*SEE INSTRUCTIONS

CUSIP No. 002824 10 0 13G Page 4 of 12 Pages


 
 
1   NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

 
 
Greg W. Linder
393-58-5640
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 
 
 
 
 
 
 
 
(a)
 
/ /
                (b)   /x/
3   SEC USE ONLY

 
 
 
 
 
 
 
 
 
 
 
4   CITIZENSHIP OR PLACE OF ORGANIZATION

 
 
United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH   5   SOLE VOTING POWER
            10,531 shares— direct (Does not include shares held in the Abbott Laboratories Stock Retirement Trust for the benefit of the reporting person.)
       
        6   SHARED VOTING POWER

 
 
 
 
 
 
94,484,681—See Attached Exhibit 1
       
        7   SOLE DISPOSITIVE POWER

 
 
 
 
 
 
10,531 shares (see note in 5 above)
direct
       
        8   SHARED DISPOSITIVE POWER

 
 
 
 
 
 
94,484,681—See Attached Exhibit 1
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 
 
94,611,123—(Total of 5 + 6 + 115,911 shares—right to acquire by exercise of stock options.)
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 
 
 
 
 
 
 
 
 
 
 
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 
 
5.7%
12   TYPE OF REPORTING PERSON*

 
 
IN

*SEE INSTRUCTIONS

CUSIP No. 002824 10 0 13G Page 5 of 12 Pages


 
 
1   NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

 
 
Thomas M. Wascoe
397-44-7210
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

 
 
 
 
 
 
 
 
(a)
 
/ /
                (b)   /x/
3   SEC USE ONLY

 
 
 
 
 
 
 
 
 
 
 
4   CITIZENSHIP OR PLACE OF ORGANIZATION

 
 
United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH   5   SOLE VOTING POWER
            7,348 shares— direct (Does not include shares held in the Abbot Laboratories Stock Retirement Trust for the benefit of the reporting person.)
       
        6   SHARED VOTING POWER

 
 
 
 
 
 
94,484,681—See Attached Exhibit 1
       
        7   SOLE DISPOSITIVE POWER

 
 
 
 
 
 
7,348 shares (see note in 5 above)
direct
       
        8   SHARED DISPOSITIVE POWER

 
 
 
 
 
 
94,484,681—See Attached Exhibit 1
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 
 
94,670,054—(Total of 5 + 6 + 178,025 shares—right to acquire by exercise of stock options.)
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 
 
 
 
 
 
 
 
 
 
 
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 
 
5.7%
12   TYPE OF REPORTING PERSON*

 
 
IN

*SEE INSTRUCTIONS


Item 1(a)    Name of Issuer:


Item 1(b)    Address of Issuer's Principal Executive Offices:


Item 2(a)    Name of Persons Filing:


Item 2(b)    Address of Principal Business Office:


Item 2(c)    Citizenship:


Item 2(d)    Title of Class of Securities:


Item 2(e)    CUSIP Number:


Item 3.    If this statement is filed pursuant to § 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is an:


Item 4.    Ownership


Item 5.    Ownership of Five Percent or Less of a Class


Item 6.    Ownership of More than Five Percent on Behalf of Another Person.


Item 7.    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.


Item 8.    Identification and Classification of Members of the Group.


Item 9.    Notice of Dissolution of Group.


Item 10.    Certification.

Signature

        After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. This statement is filed on behalf of each individual listed below pursuant to their agreement.


Date: January 25, 2002
ABBOTT LABORATORIES STOCK
RETIREMENT TRUST

 
/s/  THOMAS C. FREYMAN      
Thomas C. Freyman, Co-Trustee

 
/s/  GREG W. LINDER      
Greg W. Linder, Co-Trustee

 
/s/  THOMAS M. WASCOE      
Thomas M. Wascoe, Co-Trustee


QuickLinks